Dat Ngo

11PUBLICATIONS
23CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCardiology (incl. cardiovascular diseases)Psychological methodology, design and analysisMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Nov 20, 2025
FLAG-Ida-Venetoclax vs CLIA-venetoclax for relapsed and refractory AML during a fludarabine shortage: A single center experience.

Jose Tinajero, Dat Ngo, Brian Lee

|Sep 01, 2025
The efficacy of targeted and immune-based therapies in adults with TP53-mutated acute lymphoblastic leukaemia.

Hoda Pourhassan, Jose Tinajero, Huiyan Ma

|May 23, 2025
Role of ROCK2 inhibitors in the treatment of chronic graft-versus-host disease.

Dat Ngo, Jose Tinajero, Salman Otoukesh

|Jan 17, 2025
TP53 mutations are associated with CD19- relapse and inferior outcomes after blinatumomab in adults with ALL.

Ibrahim Aldoss, Shanpeng Li, Jianying Zhang

Pageof 2